Showing results (1-10 of 693) with videos related to

Sort By:
Pageof 70
Immunotargets and Therapy|April 30, 2024
Clinical Significance of Uncommon, Non-Clinical, and Novel AutoantibodiesMichael R Shurin, Sarah E Wheeler
Microbiology Spectrum|August 4, 2021
Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy SubjectsSarah E Wheeler, Galina V Shurin, Mary Yost, et al.
The Journal of Applied Laboratory Medicine|January 21, 2022
Pilot Verification of a Novel Approach to Remove Electrophoretic Interference of the Therapeutic Monoclonal Antibody DaratumumabVandana Baloda, Michael R Shurin, Sarah E Wheeler
Clinical Biochemistry|November 1, 2019
A novel approach to remove interference of therapeutic monoclonal antibody with serum protein electrophoresisLi Liu, Michael R Shurin, Sarah E Wheeler
Cancers|June 12, 2026
MAGa: Monoclonal Autoimmune GammopathiesStephanie Torres, Sarah E Wheeler, Michael R Shurin
Cells|September 13, 2025
Pathologic and Therapeutic Schwann CellsMichael R Shurin, Sarah E Wheeler, Hua Zhong, et al.
American Journal of Clinical Pathology|November 6, 2020
Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence ScreeningMegan Zilla, Bradley J Wheeler, Christian Keetch, et al.
ACS Applied Materials & Interfaces|February 17, 2021
Rapid Detection of SARS-CoV-2 Antigens Using High-Purity Semiconducting Single-Walled Carbon Nanotube-Based Field-Effect TransistorsWenting Shao, Michael R Shurin, Sarah E Wheeler, et al.
Pathogens (Basel, Switzerland)|July 2, 2021
A Cross-Sectional Study of SARS-CoV-2 Seroprevalence between Fall 2020 and February 2021 in Allegheny County, Western Pennsylvania, USALingqing Xu, Joshua Doyle, Dominique J Barbeau, et al.
The Journal of Applied Laboratory Medicine|May 24, 2020
Incidence and Management of Therapeutic Monoclonal Antibody Interference in Monoclonal Gammopathy MonitoringLi Liu, William J Wertz, Anthony Kondisko, et al.
Pageof 70